Literature DB >> 23986391

Non-tuberculous mycobacteria: a retrospective review of Scottish isolates from 2000 to 2010.

Clark D Russell1, Pauline Claxton2, Christine Doig2, Amie-Louise Seagar2, Alan Rayner2, Ian F Laurenson2.   

Abstract

There is growing recognition of the clinical importance of non-tuberculous mycobacteria (NTM), a group of versatile opportunistic bacterial pathogens. We describe the characteristics of NTM isolates in Scotland over an 11-year period using data held by the Scottish Mycobacteria Reference Laboratory. American Thoracic Society microbiological criteria were used to evaluate the clinical significance of isolates. Data presented include analysis of trends across time, species/body site associations, gender and age differences, geographical variations and the association between cystic fibrosis and Mycobacterium abscessus. We emphasise the need for standardised reporting criteria for NTM isolates to ensure optimal surveillance of NTM disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Atypical Mycobacterial Infection; Respiratory Infection

Mesh:

Year:  2013        PMID: 23986391     DOI: 10.1136/thoraxjnl-2013-204260

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Fei Chen; Eva P Szymanski; Kenneth N Olivier; Xinyue Liu; Hervé Tettelin; Steven M Holland; Priya Duggal
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

2.  Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Authors:  Shelby Daniel-Wayman; Getahun Abate; Daniel L Barber; Luiz E Bermudez; Rhea N Coler; Michael H Cynamon; Charles L Daley; Rebecca M Davidson; Thomas Dick; R Andres Floto; Emily Henkle; Steven M Holland; Mary Jackson; Richard E Lee; Eric L Nuermberger; Kenneth N Olivier; Diane J Ordway; D Rebecca Prevots; James C Sacchettini; Max Salfinger; Christopher M Sassetti; Christine F Sizemore; Kevin L Winthrop; Adrian M Zelazny
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

3.  Historical evolution of the diseases caused by non-pigmented rapidly growing mycobacteria in a University Hospital.

Authors:  M Garcia-Coca; G Rodriguez-Sevilla; M C Muñoz-Egea; C Perez-Jorge; N Carrasco-Anton; J Esteban
Journal:  Rev Esp Quimioter       Date:  2019-09-19       Impact factor: 1.553

4.  Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Won-Jung Koh; Byeong-Ho Jeong; Kyeongman Jeon; Hye Yun Park; Su-Young Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

5.  Isolation and identification of nontuberculous mycobacteria from hospitalized patients and drinking water samples--examination of their correlation by chemometrics.

Authors:  Eleni Dovriki; Irini Gerogianni; Efi Petinaki; Christos Hadjichristodoulou; Agelos Papaioannou; Kostas Gourgoulianis
Journal:  Environ Monit Assess       Date:  2016-03-28       Impact factor: 2.513

6.  Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.

Authors:  H Kotilainen; V Valtonen; P Tukiainen; T Poussa; J Eskola; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-09       Impact factor: 3.267

7.  Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection.

Authors:  Su-Young Kim; Hye Yun Park; Byeong-Ho Jeong; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Seung-Jung Han; Sung Jae Shin; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

8.  Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.

Authors:  Dilek Satana; Gonca Erkose-Genc; Zeynep Tamay; Meltem Uzun; Nermin Guler; Zayre Erturan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-13       Impact factor: 3.944

9.  Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.

Authors:  Neeraj M Shah; Jennifer A Davidson; Laura F Anderson; Maeve K Lalor; Jusang Kim; H Lucy Thomas; Marc Lipman; Ibrahim Abubakar
Journal:  BMC Infect Dis       Date:  2016-05-06       Impact factor: 3.090

10.  Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.

Authors:  Tavs Qvist; Tania Pressler; Niels Høiby; Terese L Katzenstein
Journal:  Respir Res       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.